Updates from ReproHH

A death from an ectopic pregnancy is preventable with early intervention and should never occur. Full stop. So, what do clinicians who interface with pregnant patients need to know about diagnosis and management, since delay—whatever its cause—is the single greatest driver of morbidity and mortality?

Emergency contraception (EC) is contraception after unprotected sex. People commonly think of EC as levonorgestrel (LNG-EC), most commonly known as the "morning-after pill,” or Plan B. However, there are five forms of emergency contraception with dozens of different names. Some are more effective than others, and there are some rules to remember about them, too.

Polycystic ovary syndrome (PCOS) has a new name: Polyendocrine Metabolic Ovarian Syndrome (PMOS). While the name has changed, the diagnostic criteria and evidence-based management remain largely unchanged. The new terminology better reflects the multisystem nature of the condition.

One year ago, the Reproductive Health Hotline (ReproHH) answered its first call. What began as an ambitious effort to provide clinicians with rapid, evidence-based reproductive health consultation has quickly become a trusted resource for healthcare professionals nationwide.

As we witness the rise of ICE raids across immigrant communities, it is critical for reproductive health providers to recognize the impact of institutional violence on pregnant patients and their ability to access care.

Black birthing individuals face a risk of death that is almost four times higher than that of White birthers — a stark reflection of systemic inequities in healthcare and society.

In the United States, 1 in 4 people are not up to date on cervical cancer screening, and nearly half of those diagnosed with cervical cancer have either never been screened or are overdue for screening, and 90% of cervical cancers are attributable to HPV.

ReproHH trialed the new REMS enrollment and created a step-by-step guide for clinicians to complete their certification.

Have you heard that Depo medroxyprogesterone acetate (DMPA) use is associated with a brain tumor called meningioma? Here's what you need to know.

We are honored to have the Reproductive Health Hotline (ReproHH) named in this review as one of the primary resources for clinicians seeking information on clinical best practices and the standard of care.